No. S 157
Central Provident Fund Act
(CHAPTER 36)
Central Provident Fund
(Medisave Account Withdrawals)
(Amendment No. 2) Regulations 2021
In exercise of the powers conferred by section 77(1)(j) of the Central Provident Fund Act, the Minister for Manpower, after consulting with the Central Provident Fund Board, makes the following Regulations:
Citation and commencement
1.  These Regulations are the Central Provident Fund (Medisave Account Withdrawals) (Amendment No. 2) Regulations 2021 and come into operation on 15 March 2021.
Amendment of regulation 2
2.  Regulation 2(1) of the Central Provident Fund (Medisave Account Withdrawals) Regulations (Rg 17) (called in these Regulations the principal Regulations) is amended —
(a)by inserting, immediately after the definition of “approved remote consultation”, the following definition:
“ “approved renal dialysis premises” means any premises that the Minister charged with the responsibility for health approves for the type of renal dialysis treatment received;”; and
(b)by deleting the definition of “renal dialysis treatment” and substituting the following definition:
“ “renal dialysis treatment” means any of following:
(a)haemodialysis;
(b)continuous ambulatory peritoneal dialysis;
(c)automated peritoneal dialysis;
(d)any other treatment received for the purpose of purifying the blood of waste metabolites accumulated as a result of renal failure, that is approved by the Minister charged with the responsibility for health for the purposes of this Part;”.
Amendment of regulation 4
3.  Regulation 4(4) of the principal Regulations is amended by inserting, immediately after the words “approved medical institution”, the words “or approved renal dialysis premises (if applicable)”.
Amendment of regulation 13
4.  Regulation 13(1) of the principal Regulations is amended by deleting the words “and 14B” and substituting the words “, 14B and 19”.
Amendment of regulation 19
5.  Regulation 19 of the principal Regulations is amended —
(a)by inserting, immediately after the words “dependants of the member” in paragraph (1), the words “as an out‑patient”;
(b)by deleting the words “Minister for Health” wherever they appear in paragraphs (1) and (3) and substituting in each case the words “Minister charged with the responsibility for health”;
(c)by deleting paragraph (2) and substituting the following paragraph:
(2)  Despite anything in this Part but subject to paragraph (1) and regulations 4(4) and (6), 21C, 21D and 24, where a member or his dependant has received renal dialysis treatment as an out‑patient on or after 15 March 2021 at approved renal dialysis premises, the amount that may be withdrawn by the member from the member’s medisave account for the payment of approved costs for that treatment must not exceed —
(a)the sum of $450 per month per patient;
(b)the total expenditure incurred on approved costs; or
(c)the total credit balance in the member’s medisave account,
whichever is the lowest.”;
(d)by deleting the words “, where a member” in paragraph (2A) and substituting the words “but subject to paragraph (4) and regulation 4(4) and (6), where a member or the member’s dependant”;
(e)by inserting, immediately after the words “as an out‑patient” in paragraph (3), the words “at approved renal dialysis premises”; and
(f)by deleting paragraphs (4) and (5) and substituting the following paragraphs:
(4)  Despite paragraph (2A), no amount may be withdrawn under regulation 5 for the payment of charges incurred for any renal dialysis treatment received by a member or the member’s dependant as an in-patient for any of the following:
(a)the purchase of an ultra-violet machine for sterilization;
(b)the purchase of a dialysis machine.
(5)  In this regulation, “approved costs”, in relation to renal dialysis treatment received at approved renal dialysis premises, means the costs approved by the Minister charged with the responsibility for health for the type of renal dialysis treatment received at such approved renal dialysis premises but excludes the following:
(a)any consultation fee incurred by the member or the member’s dependant;
(b)the purchase of an ultra‑violet machine for sterilization;
(c)the purchase of a dialysis machine.”.
Amendment of regulation 24
6.  Regulation 24 of the principal Regulations is amended —
(a)by deleting sub-paragraph (g) of paragraph (1) and substituting the following sub‑paragraph:
(g)any renal dialysis treatment received on or after 1 January 2009 as an in-patient at an approved centre or approved hospital or as an out‑patient at approved renal dialysis premises;”; and
(b)by deleting paragraph (4).
Amendment of regulation 26
7.  Regulation 26 of the principal Regulations is amended by deleting the words “approved clinic or approved centre” in paragraph (b) and substituting the words “approved medical institution or by way of approved remote consultation”.
Saving and transitional provision
8.  The principal Regulations as in force immediately before 15 March 2021 continue to apply, as if regulations 2 to 7 of these Regulations had not been enacted, to an application (pending immediately before that date or made on or after that date) for the withdrawal of moneys from a member’s medisave account in respect of renal dialysis treatment received before that date.
[G.N. Nos. S 224/2007; S 527/2007; S 731/2007; S 149/2008; S 456/2008; S 682/2008; S 86/2009; S 239/2009; S 523/2009; S 659/2009; S 88/2010; S 118/2010; S 289/2010; S 548/2010; S 367/2011; S 725/2011; S 107/2013; S 482/2013; S 623/2013; S 427/2014; S 872/2014; S 177/2015; S 625/2015; S 377/2016; S 530/2016; S 723/2016; S 340/2017; S 789/2017; S 145/2018; S 341/2018; S 730/2018; S 787/2018; S 397/2019; S 200/2020; S 389/2020; S 855/2020; S 899/2020; S 1089/2020; S 131/2021]
Made on 11 March 2021.
AUBECK KAM
Permanent Secretary,
Ministry of Manpower,
Singapore.
[Plg&Pol/CPFPol/Legis/CPFSL/2021; AG/LEGIS/SL/36/2020/3 Vol. 4]
(To be presented to Parliament under section 78(2) of the Central Provident Fund Act).